XML 148 R65.htm IDEA: XBRL DOCUMENT
v3.20.4

Equity-based participation plans for associates (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2020
Statement [line items] |
Expense related to all equity-based participation and liabilities arising from equity-based payment transactions |
(USD millions) |  | 2020 |  | 2019 |  | 2018 |
Expense related to equity-based participation plans |  | 958 |  | 1 067 |  | 918 |
Liabilities arising from equity-based payment transactions |  | 269 |  | 326 |  | 273 |
Schedule of unvested restricted stock units roll forward |
|  | 2020 |  | 2019 |
|  | Number of shares in millions |  | Weighted average fair value at grant date in USD |  | Fair value at grant date in USD millions |  | Number of shares in millions |  | Weighted average fair value at grant date in USD |  | Fair value at grant date in USD millions |
Non-vested shares at January 1 |  | 25.8 |  | 71.1 |  | 1 835 |  | 25.7 |  | 77.1 |  | 1 981 |
Granted |  |  |  |  |  |  |  |  |  |  |  |  |
– Annual Incentive |  | 1.1 |  | 93.7 |  | 103 |  | 1.1 |  | 78.4 |  | 86 |
– Share savings plans |  | 4.2 |  | 95.0 |  | 399 |  | 4.2 |  | 83.0 |  | 349 |
– Select North America |  | 3.3 |  | 86.7 |  | 286 |  | 5.3 |  | 64.0 |  | 339 |
– Select outside North America |  | 2.0 |  | 89.4 |  | 179 |  | 2.6 |  | 67.4 |  | 175 |
– Long-Term Performance Plan |  | 2.5 |  | 85.1 |  | 213 |  | 2.5 |  | 68.9 |  | 172 |
– Long-Term Relative Performance Plan 1 |  | 0.2 |  | 0.0 |  | 0 |  | 0.1 |  | 0.0 |  | 0 |
– Other share awards |  | 1.5 |  | 78.0 |  | 117 |  | 1.9 |  | 67.7 |  | 129 |
Vested |  | – 13.8 |  | 74.2 |  | – 1 024 |  | – 13.3 |  | 80.3 |  | – 1 068 |
Forfeited |  | – 2.0 |  | 75.3 |  | – 151 |  | – 4.3 |  | 76.3 |  | – 328 |
Non-vested shares at December 31 |  | 24.8 |  | 78.9 |  | 1 957 |  | 25.8 |  | 71.1 |  | 1 835 |
1 LTRPP grants in 2020 represent incremental payouts based on performance criteria under the plan. In 2019 the LTRPP grants are keep whole awards granted due to the spin-off of the Alcon business.
At April 8, 2019, the Alcon spin-off date, all RSU and PSU holders, who were not entitled to the dividend in kind in the form of Alcon shares received keep whole awards in Novartis shares to compensate for the loss of the Alcon value from their Novartis shares. These keep whole awards were accounted for as a modification. As they did not increase the value of the original grant, they did not lead to additional expense. In the table above, this is reflected by a zero fair value at grant date amount.
Select outside North America |
Statement [line items] |
Disclosure of number and weighted average remaining contractual life of outstanding share options |
|  | 2020 |  | 2019 |
|  | Options (millions) |  | Weighted average exercise price (USD) |  | Options (millions) |  | Weighted average exercise price (USD) |
Options outstanding at January 1 |  | 3.4 |  | 60.9 |  | 5.6 |  | 59.9 |
Sold or exercised |  | – 0.8 |  | 57.3 |  | – 2.2 |  | 58.4 |
Outstanding at December 31 |  | 2.6 |  | 62.0 |  | 3.4 |  | 60.9 |
Exercisable at December 31 |  | 2.6 |  | 62.0 |  | 3.4 |  | 60.9 |
Disclosure of range of exercise prices of outstanding share options |
Options outstanding |  |  |  |  |  |  |  | Total/ weighted average |
Number outstanding (millions) |  | 0.4 |  | 0.8 |  | 1.4 |  | 2.6 |
Remaining contractual life (years) |  | 0.0 |  | 1.0 |  | 2.0 |  | 1.4 |
Exercise price (USD) |  | 57.0 |  | 57.6 |  | 66.0 |  | 62.0 |
Select North America |
Statement [line items] |
Disclosure of number and weighted average remaining contractual life of outstanding share options |
|  | 2020 |  | 2019 |
|  | ADR options (millions) |  | Weighted average exercise price (USD) |  | ADR options (millions) |  | Weighted average exercise price (USD) |
Options outstanding at January 1 |  | 9.6 |  | 61.9 |  | 15.2 |  | 60.7 |
Sold or exercised |  | – 2.9 |  | 59.6 |  | – 5.6 |  | 58.6 |
Outstanding at December 31 |  | 6.7 |  | 62.9 |  | 9.6 |  | 61.9 |
Exercisable at December 31 |  | 6.7 |  | 62.9 |  | 9.6 |  | 61.9 |
Disclosure of range of exercise prices of outstanding share options |
ADR options outstanding |  |  |  |  |  |  |  | Total/ weighted average |
Number outstanding (millions) |  | 0.4 |  | 2.3 |  | 4.0 |  | 6.7 |
Remaining contractual life (years) |  | 0.0 |  | 1.0 |  | 2.0 |  | 1.5 |
Exercise price (USD) |  | 57.0 |  | 58.3 |  | 66.1 |  | 62.9 |

X
- Definition The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2019-01-01 -Paragraph 45 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2019-en-r&anchor=para_45_d&doctype=Standard -URIDate 2019-03-27 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the range of exercise prices for outstanding share options. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2019-01-01 -Paragraph 45 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2019-en-r&anchor=para_45_d&doctype=Standard -URIDate 2019-03-27 + Details
Name: | ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_StatementLineItems
Namespace Prefix: | nvs_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |